Ignite Creation Date:
2025-12-24 @ 12:17 PM
Ignite Modification Date:
2025-12-26 @ 6:47 AM
Study NCT ID:
NCT05110261
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-26
First Post:
2021-10-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-24
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-24
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-11-24
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-07
First Submit QC Date:
None
Study First Post Date:
2021-11-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-25
Last Update Post Date:
2025-06-26
Last Update Post Date Type:
ACTUAL